Email Us Here

Calvert Research and Oncoceutics Announce Investment Partnership to Advance ONC201 to an IND Filing

Calvert Research and Oncoceutics announced today a partnership to support the completion of preclinical development for ONC201, Oncoceutics' preclinical stage experimental anti-cancer compound.